Fingerprint
Dive into the research topics of 'Combined weekly topotecan and biweekly bevacizumab in women with platinum-resistant ovarian, peritoneal, or fallopian tube cancer: Results of a Phase 2 Study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically